Mon.Oct 17, 2022

article thumbnail

Episode 100 – Value Based Care, Data and Scale with Joseph Schulman, Senior VP Enterprise Data and Chief of Information Intelligence

Medical Device Success

Reading time: 2 – 4 minutes. 100 episodes! Wow! Hard to believe. Over 64,000 cumulative downloads. Thank you for all your support. And….you will have to keep listening because there is a lot more to share with you. Today we go back to value-based care from the providers viewpoint. Joseph Schulman is back for the second time. Joe is the Senior Vice President Enterprise Data and Chief of Information Intelligence at Northwell Health.

article thumbnail

Eyenuk raises $26M for diabetic retinopathy screening tech

MedCity News

Eyenuk, a company that makes technology for eye screenings, raised $26 million in a Series A funding round, bringing its total funding to more than $43 million. Research shows that the company’s AI system is more accurate in detecting diabetic retinopathy than a clinical examination from a general ophthalmologist or a retina specialist.

133
133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CHMP recommends Pluvicto® for treating advanced prostate cancer

European Pharmaceutical Review

Novartis announced that The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Pluvicto ® radioligand therapy for treatment of patients with prostate cancer. Pluvicto combines a targeting compound (ligand, in this case directed to PSMA) with a therapeutic radioisotope (in this case lutetium-177).

Medicine 120
article thumbnail

How to improve data literacy within healthcare organizations

MedCity News

Healthcare organizations must ensure they have a data-literate workforce that is confident in using the data and is empowered in using it to make decisions. Here are some best practices that hospitals can implement to better empower their employees to make data-driven decisions.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Fluorescence Imaging System Illuminates Tumor Depth

Medgadget

Medical researchers at Washington University School of Medicine in St. Louis have developed a fluorescence imaging technique that allows them to illuminate a tumor in situ and calculate its depth below the surface of the body. The technique could assist surgeons in accurately removing a tumor and successfully excising an appropriate margin of healthy tissue to reduce the chances of tumor recurrence.

Medicine 105
article thumbnail

Report: What drives consumers to MA plans and others to traditional Medicare

MedCity News

Many Medicare Advantage enrollees choose their plans because they offer more benefits than traditional Medicare and have limits on out-of-pocket costs. Traditional Medicare plans, however, provide more options for doctors, hospitals and providers.

Doctors 124

More Trending

article thumbnail

NGM Bio’s Merck-partnered drug for vision loss disorder flunks Phase 2 test

MedCity News

NGM Biosciences’ experimental geographic atrophy therapy failed a mid-stage test, making it less likely that drug partner Merck will exercise its option on the antibody. Meanwhile, an Apellis Pharmaceuticals drug for the same disorder is expected to receive an FDA decision by late November.

FDA 121
article thumbnail

Screening App to Diagnose Parkinson’s, COVID-19 from Voice

Medgadget

Researchers at RMIT University in Melbourne, Australia, have developed an app that is intended to provide early diagnosis for Parkinson’s disease and severe COVID-19. The artificial intelligence-powered technology works by analyzing voice recordings, having previously been trained to recognize the vocal hallmarks of these diseases by listening to recordings of patients.

article thumbnail

‘The consumer is looking for a guide’: 2 companies partner to offer OTC hearing aid counsel

MedCity News

Over-the-counter hearing aids are hitting the market, but many consumers may not know what product is best for them. Tuned and Soundly, both hearing care companies, are collaborating to provide guidance.

Marketing 111
article thumbnail

He helped discover BMS’s psoriasis pill Sotyktu. Here’s what he has to say about early science in Big Pharma

PharmaVoice

Bristol Myers Squibb’s senior principal scientist Ryan Moslin shares why his team was built for success and how they ushered a potential psoriasis blockbuster through discovery.

Pharma 98
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

In midterm speeches, President Biden focuses on Rx drug costs to cut inflation

MedCity News

President Biden continues to center his pre-midterm speeches around the issue of prescription drug costs, […].

article thumbnail

Novo Nordisk acquires Forma Therapeutics for $1.1bn

Pharmaceutical Technology

Novo Nordisk has concluded the acquisition of all outstanding shares of common stock of clinical-stage biopharmaceutical company Forma Therapeutics for $20 for each share in cash or a deal totalling $1.1bn. In September, Novo Nordisk entered a definitive agreement to acquire Forma. With the conclusion of the merger, Forma became Novo Nordisk’s fully-owned subsidiary. .

article thumbnail

Bringing the promise of immunotherapy to a broader population

pharmaphorum

When James P Allison and Tasuku Honjo were awarded the Nobel Prize for Medicine in 2018 for their discovery of cancer therapy through inhibition of negative immune regulation, it shone a light on decades of research into recruiting the immune system to fight cancer. Their success led to the discovery of an entirely new principle for cancer therapy – the field of immuno-oncology – one that is now a mainstay of cancer treatment, changing the way these diseases can be managed.

article thumbnail

The case for care management offerings for employer-sponsored health plans

MedCity News

Care management programs are well-positioned to help employers not only improve employee health and manage spend, but recommend needed care or next best steps, and influence behavior changes so adverse health events don’t happen in the first place.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

Medgadget

The COVID-19 pandemic has put lung health firmly in our minds. For those with chronic lung diseases, such as asthma and COPD, an important way to keep track of lung health is to use a spirometer to measure how well air can move in and out of the lungs during forced breathing. However, patients would typically attend with a lung specialist to perform this test.

Doctors 93
article thumbnail

Gilead pays $60M to strike up another cancer drug alliance with MacroGenics

MedCity News

Gilead Sciences is betting that a MacroGenics antibody drug for blood cancers can offer a safety edge over others that address the same target. It’s the second partnership between the two companies; an alliance that began in 2013 expired without Gilead licensing any molecules from the deal.

Safety 98
article thumbnail

CHMP recommends dengue vaccine for children

European Pharmaceutical Review

The European Medicines Agency’s human medicines committee ( CHMP ) has recommended the use of Takeda’s Dengue Tetravalent Vaccine (live, attenuated), to prevent disease caused by dengue virus serotypes 1, 2, 3 and 4 in people from four years of age to 45+. This recommendation marks the first time the CHMP has simultaneously reviewed applications for EU-aimed medicine under both the centralised procedure and the EMA’s ‘EU-Medicines for all’ (EU-M4all) programme for non-EU countries.

article thumbnail

Parliament square set for ME research demonstration

PharmaTimes

Demonstrators will demand hundreds of millions of pounds ‘missing’ from ME research

127
127
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Enterin and Parkinson’s UK to partner on dementia study

European Pharmaceutical Review

US biopharma company Enterin Inc. and Parkinson’s UK’s drug development and discovery division, Parkinson’s Virtual Biotech , will collaborate on a new Phase II trial to study the effects of the drug ENT-01 on Parkinson’s Disease (PD)-associated dementia. . The partnership will build on research from Enterin’s randomised, placebo-controlled Phase II trial earlier this year.

article thumbnail

Fun(ny) Facts: Humor as a Research Communication Strategy

Copyright Clearance Center

The post Fun(ny) Facts: Humor as a Research Communication Strategy appeared first on Copyright Clearance Center.

98
article thumbnail

Sanofi to sell Japanese manufacturing plant

European Pharmaceutical Review

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO. The goal is for the CDMO to become a strategic partner to introduce new European, North American and Japanese customers to the manufacturing plant.

article thumbnail

The Novartis US Foundation’s president on the ‘magical piece’ of its 10-year health equity plan

PharmaVoice

Dr. Patrice Matchaba discusses Novartis’ end-to-end approach to tackling systemic health disparities.

98
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Frankfurt Spotlight: Small-Batch Publishing?

Copyright Clearance Center

The post Frankfurt Spotlight: Small-Batch Publishing? appeared first on Copyright Clearance Center.

98
article thumbnail

Beyond Static Reports – Dynamic Dashboards for Patient-Level Insights

PharmExec

In the past, patient-level insights were achieved through time-consuming methods requiring substantial manual effort to produce static reports. With the help of technology and machine learning, that’s no longer the case. Join Andy Burch and Brian Smith, two thought leaders with a breadth of experience in AI-ML solutions, as they dive into the benefits of bringing automated data in to dynamic visualization products and how they can help you achieve instant insights.

article thumbnail

Immediate steps are needed to reduce the ‘twindemic’ impact in Europe and the US

Pharmaceutical Technology

Recent reports show that influenza cases are rising in the US and the UK. The intensity of the flu season in North America and Europe can be predicted by Australia’s flu season, having occurred months before the northern hemisphere’s winter period. This year, Australia experienced its worst flu season in five years. At its height, more than 30,000 cases were reported each week, according to the Australian Government Department of Health and Aged Care.

article thumbnail

How AI and Real World Data are Reshaping Medical Affairs

PharmExec

Real world data (RWD) and artificial intelligence (AI) offer an unprecedented opportunity for Medical Affairs professionals to gather and share deeper insights about patients, including insights regarding disease progression, outcomes, and treatment response, as well as additional insights about patients’ journeys prior to diagnosis and after treatment initiation.

Medical 64
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Does your copay program factor in differences across specialties? GoodRx analysis shows it should.

PharmaVoice

New findings reveal an out-of-pocket cost gap between brand-name and generic prescriptions. To address this gap, GoodRx is partnering with pharmaceutical companies to improve cost transparency and communication between patients and providers.

article thumbnail

NHS Confederation responds to the appointment of Jeremy Hunt

PharmaTimes

New Chancellor of the Exchequer left in no doubt regarding challenges ahead

97
article thumbnail

Cancer Vaccine May be Effective for Melanoma Patients

Pharmacy Times

A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.

article thumbnail

Oracle and Cerner: A Leap Forward in Safety

PharmExec

October 18th 2022 9 am CT |10 am ET | 3 pm BST | 4 pm CET Oracle’s market-leading safety software solutions provide highly powerful technology and algorithms for data mining. Combining Cerner Enviza’s real-world datasets containing de-identified, person-centric, longitudinal records offers a vast resource for expanding the potential of safety signaling.

Safety 52
article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.